Journey Clinical

Our mission is to expand access to revolutionizing psychedelic therapies.

We are facing a mental health crisis with 100M+ people suffering from depression and anxiety in the US, and legacy treatments don’t always work. Legal and evidence-based psychedelic therapies introduce a paradigm shift in the treatment of mental health. At Journey Clinical, we are building a Telehealth platform to empower the 1M+ licensed psychotherapists nationwide to offer psychedelic therapies in their own practice, starting with FDA-approved ketamine. With a decentralized clinic model, Journey Clinical takes care of the medical aspect of the treatment in-house while Journey member psychotherapists are in charge of psychotherapy. Our collaborative care model provides a robust care management system and optimizes clinical outcomes for patients.

Journey Clinical is backed by top tier investors (Fifty Years, Neo Kuma Ventures, Palo Santo, PsyMed Ventures, Lionheart Ventures, Christina Sass co-founder of Andela, ​​Edvard Engesæth, MD co-founder of Nurx and, Hans Gangeskar co-founder of Nurx, etc.) as featured in TechCrunch. 

We are creating an open-minded and inclusive workplace where you will have the opportunity to grow and collaborate with a diverse team of high performing individuals. Our team combines extensive experience in business and healthcare. We are mission driven and strive to make the workplace stimulating, ethical, rewarding, and fun. Together, we will be working at the cutting edge of a groundbreaking field that is reshaping mental health and we will make a direct impact on people’s lives!